Celecoxib suppresses cutaneous squamous-cell carcinoma cell migration via inhibition of SDF1-induced endocytosis of CXCR4

BACKGROUND: Cutaneous squamous cell carcinoma (CSCC), the main type of non-melanoma skin cancer (NMSC), contributes to 20-30% of the overall number of NMSC cases. Some CSCCs are observed to have metastatic potential induced by solar ultra violet (UV) radiation. Celecoxib, a nonsteroidal anti-inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Ting, Yu, Yan, Yang, Bo, Lin, Min, Huang, Jin-Wen, Cheng, Bo, Ji, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239104/
https://www.ncbi.nlm.nih.gov/pubmed/30519048
http://dx.doi.org/10.2147/OTT.S180472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239104/
https://www.ncbi.nlm.nih.gov/pubmed/30519048
http://dx.doi.org/10.2147/OTT.S180472

Ejemplares similares